,Variant_classification,Gene_classification,Comment,Difficultregion,CNV-SNV,ID,OMIM_Phenotype,Disease,Clinical_synopsis,OMIM_Link,Uniprot,Inheritance,Zygosity,CHR,POS,REF,ALT,Flank,Repeat_flag,FILTER,FORMAT,VAF,Pileup_data,Mutation_type,Gene_name,Entrez_Gene_Id,In_Key_Gene,HGVS_nomenclature,HGMD_transcript,ExonNumber,PolarChange,1000G_ASN_AF,1000G_ALL_AF,ESP6500_AC,ESP6500_AF,gnomAD_exome_ALL,gnomAD_exome_EAS,gnomAD_genome_ALL,gnomAD_genome_EAS,ExAC_EAS_HomoAlt_Count,ExAC_EAS_AC,ExAC_EAS_AF,ExAC_HomoAlt_Count,ExAC_AC,ExAC_AF,In_house_freq,In_house_count,ExAC_Link,ExAC_MisZ,ExAC_Expected,ExAC_observed,ExAC_PLI,PLI_Link,Phylop_Vertebrate_score,Phylop_Mammal_score,SIFT_score,SIFT_prediction,Polyphen2_HDIV_score,Polyphen2_HDIV_pred,Polyphen2_HVAR_score,Polyphen2_HVAR_pred,LRT_score,LRT_prediction,Mutationtatser_score,Mutationtatser_prediction,Gerp++,CADD,Rs_ID,Swiss_prot_function,Swiss_prot_disease_association,Swiss_prot_post_translational_modifications,Swiss_prot_expression,HGMD_mutation_type,HGMD_variant_class,HGMD_disease,HGMD_pubmed_ID,HGMD_indel_type,HGMD_Indel_class,HGMD_indel_disease,HGMD_indel_PMID,HGMD_nearby_alleles,Clinvar,Clinvar_Link,CosmicID,Cosmic_Occurence,Mother_zygosity,Mother_filter,Mother_format,Mother_VAF,Mother_pileup,Father_zygosity,Father_filter,Father_format,Father_VAF,Father_pileup,Recessive,Com_het,De_novo,Other_relatives,Covered,Less_20,GO_BP,GO_CC,GO_MF,KEGG_PATHWAY,PID_PATHWAY,BIOCARTA_PATHWAY,REACTOME_PATHWAY,pheno_rank,intersect_rank,CaseID
17,.,.,HGMD|OMIM,.,.,R17003113LU01-AX338M,300496;300673;300260;300055;312750,"Autism susceptibility, X-linked 3;Encephalopathy, neonatal severe;Mental retardation, X-linked syndromic, Lubs type;Mental retardation, X-linked, syndromic 13;Rett syndrome;Rett syndrome, atypical;Rett syndrome, preserved speech variant","1.$$$mimNumber,300496###prefix,####preferredTitle,AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3###inheritance,X-linked ;###inheritance,Multifactorial ;###inheritance,Isolated cases ###neurologicCentralNervousSystem,Impaired social interaction ;###neurologicCentralNervousSystem,Impaired use of nonverbal behaviors, such as eye-to-eye gaze, facial expression, body posture, and gestures ;###neurologicCentralNervousSystem,Lack of peer relationships ;###neurologicCentralNervousSystem,Impaired language development ;###neurologicCentralNervousSystem,Lack of spontaneous play ;###neurologicCentralNervousSystem,Restrictive behavior, interests, and activities ;###neurologicCentralNervousSystem,Stereotyped, repetitive behavior ;###neurologicCentralNervousSystem,Inflexible adherence to routines or rituals ;###neurologicCentralNervousSystem,Mental retardation in 75% ;###neurologicCentralNervousSystem,Seizures in 15-30% ;###neurologicCentralNervousSystem,EEG abnormalities in 20-50% ###laboratoryAbnormalities,Increased serum serotonin in 25% ###miscellaneous,Onset by 3 years of age ;###miscellaneous,Male to female ratio 4:1 ;###miscellaneous,Occurs in 2-5 per 10,000 individuals ;###miscellaneous,Genetic heterogeneity (see ;###miscellaneous,Associated with tuberous sclerosis ();###miscellaneous,Associated with untreated phenylketonuria ();###miscellaneous,Genetic heterogeneity (see ;###miscellaneous,Allelic disorder to Rett syndrome ()###molecularBasis,Susceptibility conferred by mutation in the methyl-CpG binding protein-2 gene (MECP2, ) 2.$$$mimNumber,300673###prefix,####preferredTitle,ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS###inheritance,X-linked recessive ###growthOther,Failure to thrive ###headAndNeckHead,Microcephaly, progressive ###respiratory,Respiratory insufficiency ;###respiratory,Apnea ;###respiratory,Central hypoventilation ###abdomenGastrointestinal,Poor feeding ;###abdomenGastrointestinal,Gastroesophageal reflux ###neurologicCentralNervousSystem,Encephalopathy, severe, neonatal ;###neurologicCentralNervousSystem,Developmental delay, severe ;###neurologicCentralNervousSystem,Mental retardation, severe ;###neurologicCentralNervousSystem,Seizures ;###neurologicCentralNervousSystem,Axial hypotonia ;###neurologicCentralNervousSystem,Hyperextension of the limbs ;###neurologicCentralNervousSystem,Limb rigidity ;###neurologicCentralNervousSystem,Hyperreflexia ;###neurologicCentralNervousSystem,Dyskinetic movements ;###neurologicCentralNervousSystem,Myoclonus ;###neurologicCentralNervousSystem,EEG abnormalities ;###neurologicCentralNervousSystem,Polymicrogyria (reported in 1 patient) ###neurologicBehavioralPsychiatricManifestations,Stereotypical movements ###miscellaneous,Onset at birth ;###miscellaneous,Death usually within first 2 years of life ;###miscellaneous,MECP2 mutations are those found in females with Rett syndrome ()###molecularBasis,Caused by mutation in the methyl-CpG-binding protein 2 gene (MECP2, ) 3.$$$mimNumber,300260###prefix,####preferredTitle,LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL###inheritance,X-linked recessive ###growthOther,No growth retardation ###headAndNeckHead,Macrocephaly ;###headAndNeckHead,Microcephaly ;###headAndNeckHead,Brachycephaly ###headAndNeckFace,Flat midface ;###headAndNeckFace,Facial hypotonia ;###headAndNeckFace,Limited facial expression ###headAndNeckEars,Large ears ;###headAndNeckEars,Low-set ears ###headAndNeckEyes,Poor eye contact ###headAndNeckNose,Flat nasal bridge ###headAndNeckMouth,Small mouth ;###headAndNeckMouth,Tented upper lip ;###headAndNeckMouth,Excessive salivation ;###headAndNeckMouth,Drooling ###headAndNeckTeeth,Bruxism ###respiratory,Recurrent respiratory infections ;###respiratory,Abnormal breathing patterns ###abdomenGastrointestinal,Dysphagia ;###abdomenGastrointestinal,Gastroesophageal reflux ;###abdomenGastrointestinal,Constipation ###genitourinaryInternalGenitaliaMale,Cryptorchidism ###skeletalSkull,Asymmetric skull ###neurologicCentralNervousSystem,Severe psychomotor retardation from birth ;###neurologicCentralNervousSystem,Hypotonia, infantile ;###neurologicCentralNervousSystem,Loss of any acquired abilities in early childhood ;###neurologicCentralNervousSystem,Seizures ;###neurologicCentralNervousSystem,Spasticity, progressive, develops in childhood ;###neurologicCentralNervousSystem,Ataxia ;###neurologicCentralNervousSystem,Choreiform movements ;###neurologicCentralNervousSystem,Lack of language development ;###neurologicCentralNervousSystem,Sleep disturbances ###neurologicBehavioralPsychiatricManifestations,Bruxism ;###neurologicBehavioralPsychiatricManifestations,Stereotypic hand movements ;###neurologicBehavioralPsychiatricManifestations,Loss of purposeful hand movements ;###neurologicBehavioralPsychiatricManifestations,Autistic features ;###neurologicBehavioralPsychiatricManifestations,Rigidity ;###neurologicBehavioralPsychiatricManifestations,Depression ;###neurologicBehavioralPsychiatricManifestations,Anxiety ;###neurologicBehavioralPsychiatricManifestations,Compulsions ;###neurologicBehavioralPsychiatricManifestations,Hostility ;###neurologicBehavioralPsychiatricManifestations,Psychoticism ###laboratoryAbnormalities,Female carriers show markedly skewed X inactivation ###miscellaneous,Progressive disorder ;###miscellaneous,Female carriers are unaffected or show neuropsychiatric features ;###miscellaneous,Allelic to Rett syndrome ()###molecularBasis,Caused by duplication of the methyl-Cp6-binding protein 2 gene (MECP2, ) 4.$$$mimNumber,300055###prefix,####preferredTitle,MENTAL RETARDATION, X-LINKED, SYNDROMIC 13; MRXS13###inheritance,X-linked recessive ###headAndNeckHead,Microcephaly ###headAndNeckFace,Micrognathia ;###headAndNeckFace,Facial hypotonia ###headAndNeckEars,Large ears ###headAndNeckMouth,High-arched palate ;###headAndNeckMouth,Sialorrhea ###headAndNeckTeeth,Bruxism ###headAndNeckNeck,Short neck ###genitourinaryExternalGenitaliaMale,Macroorchidism (described in 1 family) ###skeletalFeet,Pes cavus ###muscleSoftTissue,Distal atrophy of the legs ###neurologicCentralNervousSystem,Mental retardation ;###neurologicCentralNervousSystem,Delayed development ;###neurologicCentralNervousSystem,Delayed speech ;###neurologicCentralNervousSystem,Spasticity ;###neurologicCentralNervousSystem,Tremor ;###neurologicCentralNervousSystem,Ataxia ;###neurologicCentralNervousSystem,Parkinsonism ;###neurologicCentralNervousSystem,Shuffling gait ;###neurologicCentralNervousSystem,Spastic gait ;###neurologicCentralNervousSystem,Hyperreflexia ;###neurologicCentralNervousSystem,Increased tone ;###neurologicCentralNervousSystem,Extensor plantar responses ;###neurologicCentralNervousSystem,Choreoathetosis (described in 1 patient) ;###neurologicCentralNervousSystem,Seizures ;###neurologicCentralNervousSystem,EEG abnormalities ###neurologicBehavioralPsychiatricManifestations,Psychosis ;###neurologicBehavioralPsychiatricManifestations,Mood instability ;###neurologicBehavioralPsychiatricManifestations,Schizophrenic symptoms (reported in 1 patient) ###miscellaneous,Slowly progressive ;###miscellaneous,Highly variable phenotype with respect to facial dysmorphism and neurologic features ;###miscellaneous,Female carriers may have mild mental retardation ;###miscellaneous,Allelic to Rett syndrome ()###molecularBasis,Caused by mutation in the methyl-CpG-binding protein 2 gene (MECP2, ). 5.$$$mimNumber,312750###prefix,####preferredTitle,RETT SYNDROME; RTT###inheritance,X-linked dominant ###growthHeight,Short stature ###growthWeight,Cachexia ###headAndNeckHead,Normal birth head circumference ;###headAndNeckHead,Deceleration of head growth ;###headAndNeckHead,Microcephaly ###headAndNeckTeeth,Bruxism ###cardiovascularHeart,Prolonged QTc interval ;###cardiovascularHeart,T-wave abnormalities ###respiratory,Periodic apnea while awake ;###respiratory,Intermittent hyperventilation ;###respiratory,Breath holding ###abdomenGastrointestinal,Constipation ;###abdomenGastrointestinal,Gastroesophageal reflux ###skeletalSpine,Scoliosis ;###skeletalSpine,Kyphosis ###skeletalFeet,Small feet ;###skeletalFeet,Cold feet ;###skeletalFeet,Vasomotor disturbance ###muscleSoftTissue,Muscle wasting ###neurologicCentralNervousSystem,Normal development until 6-18 months ;###neurologicCentralNervousSystem,Mental retardation, profound ;###neurologicCentralNervousSystem,Spasticity ;###neurologicCentralNervousSystem,EEG abnormalities - slow waking background, intermittent rhythmical slowing (3-5Hz), epileptiform discharges ;###neurologicCentralNervousSystem,Seizures ;###neurologicCentralNervousSystem,Reduction or loss of acquired skills (e.g., purposeful hand use, speech) ;###neurologicCentralNervousSystem,Gait ataxia ;###neurologicCentralNervousSystem,Gait apraxia ;###neurologicCentralNervousSystem,Truncal ataxia ;###neurologicCentralNervousSystem,Dystonia ;###neurologicCentralNervousSystem,Cortical atrophy (frontal area) ###neurologicBehavioralPsychiatricManifestations,Autistic behaviors ;###neurologicBehavioralPsychiatricManifestations,Hand stereotypies (e.g., hand wringing) ;###neurologicBehavioralPsychiatricManifestations,Sleep disturbance ;###neurologicBehavioralPsychiatricManifestations,Bruxism ;###neurologicBehavioralPsychiatricManifestations,Breath holding ###miscellaneous,Prevalence 1/10,000-1/15,000 female births ;###miscellaneous,Initially normal for first 6-18 months which is then followed by withdrawal and regression ;###miscellaneous,Four clinical stages - Stage I, early onset stagnation (onset 6 months-1.5 year) ;###miscellaneous,Stage II, rapid developmental regression (onset 1-4 years) ;###miscellaneous,Stage III, pseudostationary period (onset 2-10 years) ;###miscellaneous,Stage IV, late motor deterioration (when ambulation ceases) ;###miscellaneous,Most cases are sporadic ;###miscellaneous,De novo mutations occur almost exclusively on the paternally derived X chromosome ###molecularBasis,Caused by mutation in the methyl-CpG-binding protein-2 gene (MECP2, ) 6.$$$mimNumber,312750###prefix,####preferredTitle,RETT SYNDROME; RTT###inheritance,X-linked dominant ###growthHeight,Short stature ###growthWeight,Cachexia ###headAndNeckHead,Normal birth head circumference ;###headAndNeckHead,Deceleration of head growth ;###headAndNeckHead,Microcephaly ###headAndNeckTeeth,Bruxism ###cardiovascularHeart,Prolonged QTc interval ;###cardiovascularHeart,T-wave abnormalities ###respiratory,Periodic apnea while awake ;###respiratory,Intermittent hyperventilation ;###respiratory,Breath holding ###abdomenGastrointestinal,Constipation ;###abdomenGastrointestinal,Gastroesophageal reflux ###skeletalSpine,Scoliosis ;###skeletalSpine,Kyphosis ###skeletalFeet,Small feet ;###skeletalFeet,Cold feet ;###skeletalFeet,Vasomotor disturbance ###muscleSoftTissue,Muscle wasting ###neurologicCentralNervousSystem,Normal development until 6-18 months ;###neurologicCentralNervousSystem,Mental retardation, profound ;###neurologicCentralNervousSystem,Spasticity ;###neurologicCentralNervousSystem,EEG abnormalities - slow waking background, intermittent rhythmical slowing (3-5Hz), epileptiform discharges ;###neurologicCentralNervousSystem,Seizures ;###neurologicCentralNervousSystem,Reduction or loss of acquired skills (e.g., purposeful hand use, speech) ;###neurologicCentralNervousSystem,Gait ataxia ;###neurologicCentralNervousSystem,Gait apraxia ;###neurologicCentralNervousSystem,Truncal ataxia ;###neurologicCentralNervousSystem,Dystonia ;###neurologicCentralNervousSystem,Cortical atrophy (frontal area) ###neurologicBehavioralPsychiatricManifestations,Autistic behaviors ;###neurologicBehavioralPsychiatricManifestations,Hand stereotypies (e.g., hand wringing) ;###neurologicBehavioralPsychiatricManifestations,Sleep disturbance ;###neurologicBehavioralPsychiatricManifestations,Bruxism ;###neurologicBehavioralPsychiatricManifestations,Breath holding ###miscellaneous,Prevalence 1/10,000-1/15,000 female births ;###miscellaneous,Initially normal for first 6-18 months which is then followed by withdrawal and regression ;###miscellaneous,Four clinical stages - Stage I, early onset stagnation (onset 6 months-1.5 year) ;###miscellaneous,Stage II, rapid developmental regression (onset 1-4 years) ;###miscellaneous,Stage III, pseudostationary period (onset 2-10 years) ;###miscellaneous,Stage IV, late motor deterioration (when ambulation ceases) ;###miscellaneous,Most cases are sporadic ;###miscellaneous,De novo mutations occur almost exclusively on the paternally derived X chromosome ###molecularBasis,Caused by mutation in the methyl-CpG-binding protein-2 gene (MECP2, )",https://www.omim.org/entry/300496;https://www.omim.org/entry/300673;https://www.omim.org/entry/300260;https://www.omim.org/entry/300055;https://www.omim.org/entry/312750,.,"Isolated cases, X-linked, Multifactorial;X-linked recessive;X-linked dominant",Het,X,153296677,G,A,.,.,PASS,0/1:213:370,57.57,",$,aaa,,aaaaa,,aaa,,,a,,,,,,a,,,,,,a,a,,a,a,a,aaaa,,a,aaaaaa,a,A$Aaa.$a,,,.,AaaaA,a,.AAAAAAAA,.Aa.A,aaa.A.AAA..AAAAAa,a.,AA,AaA,,..Aa.A.a,AA....,.Aa,.AAAA.A,A$a.aA.Aa,,AaaAA,,AAAA.A..,aA.A..aA..aaAa.,A,,a.AA.AA.AAAAA,AA.,..,,AAA.A..A.AAAA.AA.A.AA.A.aa,A..,,..AAAA,A,AAA.A.aAAA",missense_variant;missense_variant,MECP2,4204,.,NM_004992.3(MECP2):c.602C>T(p.Ala201Val);NM_001110792.1(MECP2):c.638C>T(p.Ala213Val),NM_004992.3,exon4(4);exon3(3),NP=>NP;NP=>NP,0.012,0.0048,6,0.00057,0.0014,0.0104,0.0014,0.0079,1,70,0.011,1,135,0.0015,0.0101744186047,7/688,http://exac.broadinstitute.org/variant/X-153296677-G-A,-1.42,8.0,1,0.7,http://exac.broadinstitute.org/gene/ENSG00000169057,0.29336,7.43E-4,0.21,T,0.002,B,0.001,B,0.011,N,0.546,N,4.61,11.49,rs61748381,.,.,.,.,NM_004992.3(MECP2):c.602C>T(p.A201V),DM?,Rett syndrome,12180070,NM_004992.3(MECP2):c.601dupG,DM,Rett syndrome,10944854,.,138188,https://www.ncbi.nlm.nih.gov/clinvar/variation/138188,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,"adult locomotory behavior (GO:0008344)|behavioral fear response (GO:0001662)|cardiolipin metabolic process (GO:0032048)|catecholamine secretion (GO:0050432)|cerebellum development (GO:0021549)|chromatin silencing (GO:0006342)|dendrite development (GO:0016358)|glucocorticoid metabolic process (GO:0008211)|glutamine metabolic process (GO:0006541)|histone acetylation (GO:0016573)|histone methylation (GO:0016571)|inositol metabolic process (GO:0006020)|long-term memory (GO:0007616)|long-term synaptic potentiation (GO:0060291)|mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)|negative regulation of histone acetylation (GO:0035067)|negative regulation of histone methylation (GO:0031061)|negative regulation of neuron apoptotic process (GO:0043524)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|negative regulation of transcription, DNA-templated (GO:0045892)|neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976)|neuron maturation (GO:0042551)|pathogenesis (GO:0009405)|phosphatidylcholine metabolic process (GO:0046470)|positive regulation of cell proliferation (GO:0008284)|positive regulation of synapse assembly (GO:0051965)|positive regulation of transcription, DNA-templated (GO:0045893)|post-embryonic development (GO:0009791)|proprioception (GO:0019230)|protein localization (GO:0008104)|regulation of excitatory postsynaptic membrane potential (GO:0060079)|regulation of gene expression by genetic imprinting (GO:0006349)|regulation of respiratory gaseous exchange by neurological system process (GO:0002087)|respiratory gaseous exchange (GO:0007585)|response to hypoxia (GO:0001666)|sensory perception of pain (GO:0019233)|social behavior (GO:0035176)|startle response (GO:0001964)|synapse assembly (GO:0007416)|transcription, DNA-templated (GO:0006351)|ventricular system development (GO:0021591)|visual learning (GO:0008542)",cytosol (GO:0005829)|extracellular space (GO:0005615)|heterochromatin (GO:0000792)|nucleus (GO:0005634),chromatin binding (GO:0003682)|DNA binding (GO:0003677)|double-stranded methylated DNA binding (GO:0010385)|methyl-CpG binding (GO:0008327)|mRNA binding (GO:0003729)|poly(A) RNA binding (GO:0044822)|protein domain specific binding (GO:0019904)|protein N-terminus binding (GO:0047485)|sequence-specific DNA binding transcription factor activity (GO:0003700)|siRNA binding (GO:0035197)|transcription corepressor activity (GO:0003714),.,.,.,.,51,3,AX338
106,.,.,OMIM|novel,.,.,R17003113LU01-AX338M,616050;616115,Autoinflammation with infantile enterocolitis;?Familial cold autoinflammatory syndrome 4,"1.$$$mimNumber,616050###prefix,####preferredTitle,AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC###inheritance,Autosomal dominant ###growthHeight,Short stature ###growthOther,Failure to thrive ###abdomenSpleen,Splenomegaly ###abdomenGastrointestinal,Enterocolitis, infantile ;###abdomenGastrointestinal,Secretory diarrhea, infantile ;###abdomenGastrointestinal,Vomiting, infantile ;###abdomenGastrointestinal,Villous blunting ###skeletal,Arthralgias ###skinNailsHairSkin,Rash ###muscleSoftTissue,Myalgias ###metabolicFeatures,Fever, episodic ###hematology,Disseminated intravascular coagulation, episodic ;###hematology,Pancytopenia, episodic ###immunology,Autoinflammation, systemic ;###immunology,Activated macrophages ;###immunology,Low NK cells ;###immunology,Dysfunctional NK cells ###laboratoryAbnormalities,Increased C-reactive protein ;###laboratoryAbnormalities,Increased serum ferritin ;###laboratoryAbnormalities,Increased IL18 ;###laboratoryAbnormalities,Increased IL1B Increased soluble IL2R ###miscellaneous,Onset in neonatal period or early infancy ;###miscellaneous,Enterocolitis tends to remit with age ;###miscellaneous,Flares triggered by viral infection, overexertion, stress ;###miscellaneous,Two unrelated families have been reported (last curated October 2014) ###molecularBasis,Caused by mutation in the NLR family, caspase recruitment domain-containing 4 gene (NLRC4, ) 2.$$$mimNumber,616115###prefix,####preferredTitle,FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 4; FCAS4###inheritance,Autosomal dominant ###skeletal,Arthralgia, episodic ###skinNailsHairSkin,Rash, urticarial, episodic ;###skinNailsHairSkin,Non pruritic ###metabolicFeatures,Fever, intermittent ###immunology,Autoinflammatory disorder ###miscellaneous,Onset in early infancy (2 to 3 months of age) ;###miscellaneous,Episodic ;###miscellaneous,Symptoms usually resolve without treatment ;###miscellaneous,One Japanese family has been reported (last curated December 2014) ###molecularBasis,Caused by mutation in the NLR family, caspase recruitment domain-containing 4 gene (NLRC4, )",https://www.omim.org/entry/616050;https://www.omim.org/entry/616115,.,Autosomal dominant,Het,2,32476139,A,G,.,.,PASS,0/1:64:129,49.61,".$G$g$,$gg,g..,,.Gg..,.GG..,...G,,GGG.,ggg,gGGGGG,.,GG..,.,G..gG..G.GgGggggGg.GGGGG...G....G",missense_variant;missense_variant;missense_variant,NLRC4,58484,.,NM_001199138.1(NLRC4):c.794T>C(p.Ile265Thr);NM_001199139.1(NLRC4):c.794T>C(p.Ile265Thr);NM_021209.4(NLRC4):c.794T>C(p.Ile265Thr),NM_021209.4,exon4(9);exon4(9);exon4(9),NP=>P0;NP=>P0;NP=>P0,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,0.39,22.6,15,0.0,http://exac.broadinstitute.org/gene/ENSG00000091106,0.51057,.,0,D,0.856,P,0.473,P,0.004,N,0.655,D,3.27,15.46,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,"activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919)|activation of innate immune response (GO:0002218)|defense response to bacterium (GO:0042742)|detection of bacterium (GO:0016045)|inflammatory response (GO:0006954)|innate immune response (GO:0045087)|interleukin-1 beta secretion (GO:0050702)|nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)|positive regulation of apoptotic process (GO:0043065)|positive regulation of NF-kappaB transcription factor activity (GO:0051092)|protein homooligomerization (GO:0051260)|pyroptosis (GO:0070269)",cytosol (GO:0005829)|intracellular (GO:0005622)|IPAF inflammasome complex (GO:0072557),ATP binding (GO:0005524)|identical protein binding (GO:0042802)|magnesium ion binding (GO:0000287)|protein homodimerization activity (GO:0042803),.,.,.,.,63,4,AX338
280,.,.,HGMD|OMIM,.,.,R17003113LU01-AX338M,208000;615522;125853;613312;601665,"Arterial calcification, generalized, of infancy, 1;Cole disease;Diabetes mellitus, non-insulin-dependent, susceptibility to;Hypophosphatemic rickets, autosomal recessive, 2;Obesity, susceptibility to","1.$$$mimNumber,208000###prefix,####preferredTitle,ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1###inheritance,Autosomal recessive ###growthHeight,Short stature (in some patients) ###headAndNeckEars,Deafness, conductive (in some patients) ###headAndNeckEyes,Angioid retinal streaks (in some patients) ###headAndNeckNeck,Pseudoxanthomatous skin lesions (in some patients) ###cardiovascularHeart,Coronary artery calcification ;###cardiovascularHeart,Myocardial infarction ;###cardiovascularHeart,Cardiac dysfunction ;###cardiovascularHeart,Heart failure ###cardiovascularVascular,Generalized calcification of arteries, including aorta and intraparenchymal arteries ;###cardiovascularVascular,Arterial stenosis due to myointimal proliferation ;###cardiovascularVascular,Hypertension ;###cardiovascularVascular,Panarteritis (rare) ###abdomenExternalFeatures,Periumbilical pseudoxanthomatous skin lesions (in some patients) ###skeletal,Periarticular calcification (in some patients) ;###skeletal,Hypophosphatemic rickets (in some patients) ###skinNailsHairSkin,Pseudoxanthomatous skin lesions (in some patients) ###metabolicFeatures,Hypophosphatemia due to decreased renal tubular phosphate reabsorption ###miscellaneous,Most patients die in infancy ;###miscellaneous,Features of pseudoxanthoma elasticum seen in later childhood in some surviving patients ###molecularBasis,Caused by mutation in the ectonucleotide pyrophosphatase/phosphodiesterase-1 gene (ENPP1, ) 2.$$$mimNumber,615522###prefix,####preferredTitle,COLE DISEASE; COLED###inheritance,Autosomal dominant ###headAndNeckMouth,Normal teeth ###chestBreasts,Microcalcifications on mammography (in some patients) ###abdomenSpleen,Splenic calcification (in some patients) ###skeletalPelvis,Calcific tendinopathy of hips (in some patients) ###skeletalLimbs,Calcific tendinopathy of shoulders (in some patients) ;###skeletalLimbs,Calcific tendinopathy of wrists (in some patients) ###skeletalFeet,Calcific tendinopathy of heels (in some patients) ###skinNailsHairSkin,Hypopigmented macules, primarily on extremities ;###skinNailsHairSkin,Punctate palmoplantar keratoderma ###skinNailsHairSkinHistology,Hyperkeratosis ;###skinNailsHairSkinHistology,Hyperorthokeratosis ;###skinNailsHairSkinHistology,Hypergranulosis ;###skinNailsHairSkinHistology,Acanthosis ;###skinNailsHairSkinHistology,Reduction in melanin content in keratinocytes ;###skinNailsHairSkinHistology,Normal melanin content in melanocytes ;###skinNailsHairSkinHistology,Normal number of melanocytes ;###skinNailsHairSkinHistology,Small deposits of calcium in papillary dermis (in some patients) ###skinNailsHairSkinElectronMicroscopy,Increased melanosomes in cytoplasm and dendrites of melanocytes ;###skinNailsHairSkinElectronMicroscopy,Paucity of melanosomes in keratinocytes ###skinNailsHairNails,Normal nails ###skinNailsHairHair,Normal hair ###muscleSoftTissue,Calcific tendinopathy, early-onset (in some patients) ###miscellaneous,Skin lesions manifest in the first year of life ;###miscellaneous,Hair, teeth, and nails are normal ###molecularBasis,Caused by mutation in the ectonucleotide pyrophosphatase/phosphodiesterase-1 gene (ENPP1, ) 3.$$$mimNumber,601665###prefix,####preferredTitle,OBESITY###inheritance,Autosomal dominant ;###inheritance,Autosomal recessive ;###inheritance,Multifactorial ###growthWeight,Obesity ###metabolicFeatures,Obesity ;###metabolicFeatures,Reduced energy expenditure ###miscellaneous,Variable phenotypic severity ;###miscellaneous,See also leptin deficiency ()###molecularBasis,Caused by mutation in the melanocortin-4 receptor gene (MC4R, );###molecularBasis,Caused by mutation in the gamma peroxisome proliferator activated receptor gene (PPARG, );###molecularBasis,Caused by mutation in the uncoupling protein-3 gene (UCP3, );###molecularBasis,Caused by mutation in the nuclear receptor subfamily 0, group B, member 2 gene (NR0B2, );###molecularBasis,Susceptibility conferred by mutation in the ectonucleotide pyrophosphatase/phosphodiesterase 1 gene (ENPP1, );###molecularBasis,Susceptibility conferred by mutation in the ghrelin gene (GHRL, );###molecularBasis,Susceptibility conferred by mutation in the beta-2-adrenergic receptor gene (ADRB2, );###molecularBasis,Susceptibility conferred by mutation in the beta-3-adrenergic receptor gene (ADRB3, );###molecularBasis,Susceptibility conferred by mutation in the uncoupling protein-1 gene (UCP1, );###molecularBasis,Susceptibility conferred by mutation in the uncoupling protein-2 gene (UCP2, );###molecularBasis,Susceptibility conferred by mutation in the proopiomelanocortin gene (POMC, );###molecularBasis,Susceptibility conferred by mutation in the homolog of the mouse agouti gene (AGRP, );###molecularBasis,Susceptibility conferred by mutation in the cocaine- and amphetamine-regulated transcript prepropeptide (CARTPT, )",https://www.omim.org/entry/208000;https://www.omim.org/entry/615522;https://www.omim.org/entry/125853;https://www.omim.org/entry/613312;https://www.omim.org/entry/601665,.,"Autosomal recessive;Autosomal dominant;Autosomal recessive, Autosomal dominant, Multifactorial",Het,6,132203475,C,-,.,.,PASS,0/1:27:52,51.92,"...-1C.-1C.-1C.-1C..-1C.-1C,..-1C.-1C...-1C,,-1c....-1C.....-1C..-1C.-1C.-1C.-1C.",intron_variant,ENPP1,5167,.,NM_006208.2(ENPP1):c.2101-10delC,NM_006208.2,intron20(24),.,0.044,0.0088,0,0,0.0029,0.0407,0.0019,0.0339,3,368,0.043,3,375,0.0031,0.0595930232558,41/688,http://exac.broadinstitute.org/variant/6-132203474-TC-T,0.35,38.9,15,0.0,http://exac.broadinstitute.org/gene/ENSG00000197594,.,.,.,.,.,.,.,.,.,.,.,.,.,.,rs200562612,.,.,.,.,.,.,.,.,.,.,.,.,"NM_006208.2(ENPP1):c.2101-11delT,DP,Myelopathy (OPLL), association with,10453738",.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427)|ATP catabolic process (GO:0006200)|biomineral tissue development (GO:0031214)|bone remodeling (GO:0046849)|cellular phosphate ion homeostasis (GO:0030643)|cellular response to insulin stimulus (GO:0032869)|generation of precursor metabolites and energy (GO:0006091)|immune response (GO:0006955)|inorganic diphosphate transport (GO:0030505)|negative regulation of cell growth (GO:0030308)|negative regulation of fat cell differentiation (GO:0045599)|negative regulation of glucose import (GO:0046325)|negative regulation of glycogen biosynthetic process (GO:0045719)|negative regulation of insulin receptor signaling pathway (GO:0046627)|negative regulation of ossification (GO:0030279)|negative regulation of protein autophosphorylation (GO:0031953)|nucleic acid phosphodiester bond hydrolysis (GO:0090305)|nucleoside triphosphate catabolic process (GO:0009143)|phosphate-containing compound metabolic process (GO:0006796)|regulation of bone mineralization (GO:0030500)|riboflavin metabolic process (GO:0006771)|sequestering of triglyceride (GO:0030730)|small molecule metabolic process (GO:0044281)|vitamin metabolic process (GO:0006766)|water-soluble vitamin metabolic process (GO:0006767),basolateral plasma membrane (GO:0016323)|cell surface (GO:0009986)|extracellular space (GO:0005615)|integral component of membrane (GO:0016021)|integral component of plasma membrane (GO:0005887)|lysosomal membrane (GO:0005765)|plasma membrane (GO:0005886),3'-phosphoadenosine 5'-phosphosulfate binding (GO:0050656)|ATP binding (GO:0005524)|calcium ion binding (GO:0005509)|insulin receptor binding (GO:0005158)|NADH pyrophosphatase activity (GO:0035529)|nucleic acid binding (GO:0003676)|nucleoside-triphosphate diphosphatase activity (GO:0047429)|nucleotide diphosphatase activity (GO:0004551)|phosphodiesterase I activity (GO:0004528)|polysaccharide binding (GO:0030247)|protein homodimerization activity (GO:0042803)|scavenger receptor activity (GO:0005044)|zinc ion binding (GO:0008270),.,.,.,.,46,2,AX338
299,.,.,OMIM|low_frequency|possible_comhet,.,.,R17003113LU01-AX338M,608027,"?Pontocerebellar hypoplasia, type 3","1.$$$mimNumber,608027###prefix,####preferredTitle,PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3###inheritance,Autosomal recessive ###growthHeight,Short stature ###growthWeight,Low weight ###headAndNeckHead,Microcephaly ;###headAndNeckHead,Brachycephaly ###headAndNeckFace,Long philtrum ;###headAndNeckFace,Full cheeks ###headAndNeckEars,Low-set ears ;###headAndNeckEars,Large ears ;###headAndNeckEars,Hearing impairment ###headAndNeckEyes,Prominent eyes ;###headAndNeckEyes,Optic atrophy ;###headAndNeckEyes,Wide palpebral fissures ###headAndNeckNose,Depressed nasal bridge ###headAndNeckMouth,High arched palate ;###headAndNeckMouth,Downturned corners of the mouth ###neurologicCentralNervousSystem,Developmental delay, severe ;###neurologicCentralNervousSystem,Neonatal hypotonia ;###neurologicCentralNervousSystem,Poor head control ;###neurologicCentralNervousSystem,Seizures ;###neurologicCentralNervousSystem,Hyperreflexia ;###neurologicCentralNervousSystem,Truncal hypotonia ;###neurologicCentralNervousSystem,Spasticity ;###neurologicCentralNervousSystem,Small brainstem ;###neurologicCentralNervousSystem,Small cerebellum (especially vermis) ;###neurologicCentralNervousSystem,Cerebral atrophy ;###neurologicCentralNervousSystem,Hypoplasia of the corpus callosum ###miscellaneous,Onset at birth ;###miscellaneous,Progressive disorder ;###miscellaneous,One consanguineous family has been found to carry a homozygous mutation in the PCLO gene (last curated June 2015) ###molecularBasis,Caused by mutation in the homolog of the mouse piccolo gene (PCLO, )",https://www.omim.org/entry/608027,.,Autosomal recessive,Het,7,82545120,G,A,.,.,PASS,0/1:35:86,40.7,".aA.,a,AAA,.aa...,.,Aa...A,a..,.A...AAa.A.aA...A...aA.A....",missense_variant;missense_variant,PCLO,27445,.,NM_014510.2(PCLO):c.12182C>T(p.Ala4061Val);NM_033026.5(PCLO):c.12182C>T(p.Ala4061Val),NM_033026.5,exon7(20);exon7(25),NP=>NP;NP=>NP,0.001,0.0002,0,0,8.2e-06,5.875e-05,.,.,0,1,0.00013,0,2,0.000017,.,.,http://exac.broadinstitute.org/variant/7-82545120-G-A,-4.32,117.2,11,1.0,http://exac.broadinstitute.org/gene/ENSG00000186472,0.27915,.,0,D,0.775,P,0.306,B,.,.,0.553,N,5.84,11.18,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,82,5,AX338
300,.,.,OMIM|low_frequency|possible_comhet,.,.,R17003113LU01-AX338M,608027,"?Pontocerebellar hypoplasia, type 3","1.$$$mimNumber,608027###prefix,####preferredTitle,PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3###inheritance,Autosomal recessive ###growthHeight,Short stature ###growthWeight,Low weight ###headAndNeckHead,Microcephaly ;###headAndNeckHead,Brachycephaly ###headAndNeckFace,Long philtrum ;###headAndNeckFace,Full cheeks ###headAndNeckEars,Low-set ears ;###headAndNeckEars,Large ears ;###headAndNeckEars,Hearing impairment ###headAndNeckEyes,Prominent eyes ;###headAndNeckEyes,Optic atrophy ;###headAndNeckEyes,Wide palpebral fissures ###headAndNeckNose,Depressed nasal bridge ###headAndNeckMouth,High arched palate ;###headAndNeckMouth,Downturned corners of the mouth ###neurologicCentralNervousSystem,Developmental delay, severe ;###neurologicCentralNervousSystem,Neonatal hypotonia ;###neurologicCentralNervousSystem,Poor head control ;###neurologicCentralNervousSystem,Seizures ;###neurologicCentralNervousSystem,Hyperreflexia ;###neurologicCentralNervousSystem,Truncal hypotonia ;###neurologicCentralNervousSystem,Spasticity ;###neurologicCentralNervousSystem,Small brainstem ;###neurologicCentralNervousSystem,Small cerebellum (especially vermis) ;###neurologicCentralNervousSystem,Cerebral atrophy ;###neurologicCentralNervousSystem,Hypoplasia of the corpus callosum ###miscellaneous,Onset at birth ;###miscellaneous,Progressive disorder ;###miscellaneous,One consanguineous family has been found to carry a homozygous mutation in the PCLO gene (last curated June 2015) ###molecularBasis,Caused by mutation in the homolog of the mouse piccolo gene (PCLO, )",https://www.omim.org/entry/608027,.,Autosomal recessive,Het,7,82595653,G,A,.,.,PASS,0/1:41:70,58.57,"aaAa,.Aa..AA.A..aA.A.A..AAA.A.AA.AAA,..AAAAAA.A..AA^].",missense_variant;missense_variant,PCLO,27445,.,NM_033026.5(PCLO):c.3451C>T(p.Pro1151Ser);NM_014510.2(PCLO):c.3451C>T(p.Pro1151Ser),NM_033026.5,exon4(25);exon4(20),NP=>P0;NP=>P0,.,.,0,0,4.066e-05,0.0005,.,.,0,2,0.00023,0,4,0.000033,0.00145348837209,1/688,http://exac.broadinstitute.org/variant/7-82595653-G-A,-4.32,117.2,11,1.0,http://exac.broadinstitute.org/gene/ENSG00000186472,0.09443,.,0,D,0.051,B,0.033,B,.,.,1.000,N,0.68,4.965,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,82,5,AX338
372,.,.,OMIM|low_frequency,.,.,R17003113LU01-AX338M,614856,"Osteogenesis imperfecta, type XIII","1.$$$mimNumber,614856###prefix,####preferredTitle,OSTEOGENESIS IMPERFECTA, TYPE XIII; OI13###inheritance,Autosomal recessive ###growthHeight,Short stature (in some patients) ###growthWeight,Low weight (in some patients) ###headAndNeckHead,Broad forehead (in some patients) ###headAndNeckFace,Triangular face ###headAndNeckEars,Prominent ears (in some patients) ;###headAndNeckEars,No hearing impairment ###headAndNeckEyes,Wide palpebral fissures (in some patients) ;###headAndNeckEyes,Long eyelashes (in some patients) ;###headAndNeckEyes,Faint blue sclera (in some patients) ###headAndNeckMouth,Long philtrum (in some patients) ;###headAndNeckMouth,Thin lips (in some patients) ###headAndNeckTeeth,No dentinogenesis imperfecta ###cardiovascular,Normal ###chestExternalFeatures,Increased anteroposterior and transverse diameters of the thorax (in some patients) ###chestRibsSternumClaviclesAndScapulae,Pectus carinatum (in some patients) ;###chestRibsSternumClaviclesAndScapulae,Deformed clavicles (in some patients) ###abdomenExternalFeatures,Umbilical hernia (in some patients) ###skeletal,Joint hypermobility ;###skeletal,Increased bone density ;###skeletal,Decreased bone density ;###skeletal,Osteoporosis, borderline ;###skeletal,Prenatal fractures ###skeletalSkull,Wormian bones ###skeletalSpine,Vertebral fractures ;###skeletalSpine,Kyphoscoliosis ;###skeletalSpine,S-curve scoliosis of thoracic and lumbar spine ;###skeletalSpine,Platyspondyly ###skeletalLimbs,Bowing of upper extremity long bones ;###skeletalLimbs,Bowing of lower extremity long bones ;###skeletalLimbs,Limited movements of the knee joints ;###skeletalLimbs,Lack of bone modeling with wide distal metaphyses of femora ;###skeletalLimbs,Serpentine thin tibiae and fibulae ;###skeletalLimbs,Radial head dislocation (rare) ;###skeletalLimbs,Eccentric curvature and narrowing of distal ulna (rare) ###skeletalHands,Arachnodactyly (in some patients) ###muscleSoftTissue,Hypotonia (in some patients) ;###muscleSoftTissue,Muscle wasting ###neurologicCentralNervousSystem,Delayed gross motor development (in some patients) ;###neurologicCentralNervousSystem,Normal intelligence ###laboratoryAbnormalities,Normal calcium level ;###laboratoryAbnormalities,Normal phosphate level ;###laboratoryAbnormalities,Normal to slightly high alkaline phosphatase ;###laboratoryAbnormalities,Low procollagen 1 C-peptide (in some patients) ;###laboratoryAbnormalities,High deoxypyridinoline/creatinine (in some patients) ###miscellaneous,Skeletal features are variably present ###molecularBasis,Caused by mutation in the bone morphogenetic protein-1 gene (BMP1, )",https://www.omim.org/entry/614856,.,Autosomal recessive,Het,8,22064903,G,A,.,.,PASS,0/1:95:196,48.47,".$.$aaAAa.a,a,a..a,.A.,AAA..A..a.Aa,.A....A..AA.A,,A.AAAAa,,.,.,aAA,.aaAA,A.AA.A..AA.,,a,.AAa,a.,aAAA.A.a,,..A,,..AAAA.,aa,AA..A..",missense_variant,BMP1,649,.,NM_006129.4(BMP1):c.2449G>A(p.Val817Ile),NM_006129.4,exon18(20),NP=>NP,.,0.0002,0,0,6.507e-05,0.0005,9.691e-05,0.0006,0,7,0.00081,0,12,0.00010,.,.,http://exac.broadinstitute.org/variant/8-22064903-G-A,2.3,37.2,7,0.87,http://exac.broadinstitute.org/gene/ENSG00000168487,0.08731,.,0.42,T,0.002,B,0.006,B,0.063,N,0.988,D,3.48,4.551,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,cartilage condensation (GO:0001502)|cell differentiation (GO:0030154)|extracellular matrix disassembly (GO:0022617)|extracellular matrix organization (GO:0030198)|lipoprotein metabolic process (GO:0042157)|multicellular organismal development (GO:0007275)|ossification (GO:0001503)|positive regulation of cartilage development (GO:0061036)|proteolysis (GO:0006508)|skeletal system development (GO:0001501)|small molecule metabolic process (GO:0044281),extracellular region (GO:0005576)|extracellular space (GO:0005615)|Golgi apparatus (GO:0005794)|membrane-bounded vesicle (GO:0031988)|proteinaceous extracellular matrix (GO:0005578),calcium ion binding (GO:0005509)|metalloendopeptidase activity (GO:0004222)|metallopeptidase activity (GO:0008237)|peptidase activity (GO:0008233)|zinc ion binding (GO:0008270),.,.,.,.,7,0,AX338
507,.,.,HGMD|OMIM,.,.,R17003113LU01-AX338M,615083;615139,"Colorectal cancer, susceptibility to, 12;FILS syndrome","1.$$$mimNumber,615083###prefix,####preferredTitle,COLORECTAL CANCER, SUSCEPTIBILITY TO, 12; CRCS12###inheritance,Autosomal dominant ###abdomenGastrointestinal,Colorectal adenomas ;###abdomenGastrointestinal,Colorectal polyps ;###abdomenGastrointestinal,Colorectal carcinoma ###neoplasia,Colorectal carcinoma ;###neoplasia,Endometrial cancer ###miscellaneous,Tumors are microsatellite stable ;###miscellaneous,Some tumors may be microsatellite instable and carry somatic mutations in MSH mismatch repair genes ;###miscellaneous,Onset before age 40 years ;###miscellaneous,Patients develop multiple tumors ###molecularBasis,Caused by mutation in the DNA polymerase, epsilon gene (POLE, ) 2.$$$mimNumber,615139###prefix,####preferredTitle,FACIAL DYSMORPHISM, IMMUNODEFICIENCY, LIVEDO, AND SHORT STATURE; FILS###inheritance,Autosomal recessive ###growthHeight,Short stature ###headAndNeckHead,Relative macrocephaly ###headAndNeckFace,Malar hypoplasia ;###headAndNeckFace,Broad forehead ###respiratory,Recurrent respiratory infections ###skeletalLimbs,Bone pain (in some patients) ;###skeletalLimbs,Bone dysplasia (in some patients) ;###skeletalLimbs,Lacunar bone lesions (in some patients) ;###skeletalLimbs,Cortical thickening (in some patients) ;###skeletalLimbs,Modeling defects at the long bone diaphyses (in some patients) ###skinNailsHairSkin,Livedo ;###skinNailsHairSkin,Telangiectasia on the cheeks ###immunology,Immunodeficiency ;###immunology,Decreased IgM and IgG2 ;###immunology,Lack of acquired antibodies ;###immunology,Low memory B cells ;###immunology,Low naive T cells ;###immunology,Decreased T cell proliferation ###miscellaneous,Onset at birth ;###miscellaneous,One French family has been reported (last curated March 2013) ###molecularBasis,Caused by mutation in the DNA polymerase, epsilon gene (POLE, )",https://www.omim.org/entry/615083;https://www.omim.org/entry/615139,.,Autosomal dominant;Autosomal recessive,Het,12,133202740,C,T,.,.,PASS,0/1:26:56,46.43,"tTT..t.T.tt..T.T.T.TTT.T.....T.,.TT^],",missense_variant,POLE,5426,.,NM_006231.2(POLE):c.6494G>A(p.Arg2165His),NM_006231.3,exon46(49),P+=>P+,0.017,0.0098,88,0.0068,0.0059,0.0098,0.0046,0.0099,0,81,0.017,5,681,0.0092,0.0130813953488,9/688,http://exac.broadinstitute.org/variant/12-133202740-C-T,1.57,87.1,39,0.0,http://exac.broadinstitute.org/gene/ENSG00000177084,0.90623,0.006279,0.02,D,0.994,D,0.652,P,0.000,D,1.000,D,3.92,27.2,rs5745068,.,.,.,.,NM_006231.3(POLE):c.6494G>A(p.R2165H),DM?,Endometrioid endometrial carcinoma,26748215,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,"base-excision repair, gap-filling (GO:0006287)|DNA repair (GO:0006281)|DNA replication (GO:0006260)|DNA replication initiation (GO:0006270)|DNA synthesis involved in DNA repair (GO:0000731)|G1/S transition of mitotic cell cycle (GO:0000082)|in utero embryonic development (GO:0001701)|mitotic cell cycle (GO:0000278)|nucleotide-excision repair (GO:0006289)|nucleotide-excision repair, DNA gap filling (GO:0006297)|telomere maintenance (GO:0000723)|telomere maintenance via recombination (GO:0000722)|telomere maintenance via semi-conservative replication (GO:0032201)|transcription-coupled nucleotide-excision repair (GO:0006283)",cytoplasm (GO:0005737)|epsilon DNA polymerase complex (GO:0008622)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)|plasma membrane (GO:0005886),"4 iron, 4 sulfur cluster binding (GO:0051539)|chromatin binding (GO:0003682)|DNA binding (GO:0003677)|DNA-directed DNA polymerase activity (GO:0003887)|nucleotide binding (GO:0000166)|zinc ion binding (GO:0008270)",.,.,.,.,25,1,AX338
